NGS-based RNA Sequencing Industry Size Surpass USD 21.3 Billion & Expected to Witness Healthy Growth At CAGR of 22.5% Through 2032

The Global NGS-based RNA Sequencing Market was valued at USD 2.8 Billion in 2022 and it is anticipated to grow up to USD 21.3 Billion by 2032, at a CAGR of 22.5% during the forecast period.

NGS-based RNA Sequencing is used to protect against the intentional interference of electronic signals. This equipment can be used to protect against radio frequency interference (RFI), electromagnetic interference (EMI), or other types of signal interference. There are a variety of anti-jamming technologies that can be used, depending on the type of interference that is being protected against. For example, RFI jamming can be countered with frequency-hopping spread spectrum (FHSS) technology, while EMI jamming can be countered with pulse-code modulation (PCM) or other digital modulation techniques.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10519

Major Players in the Global Catamaran Market
• Agilent Technologies Inc.
• Illumina inc.
• BGI Group
• Eurofins Scientific SE
• Genewiz, Inc.
• F. Hoffman- La Roche AG
• Thermo Fisher Scientific Inc.
• Zymo Research Corporation
• Psomagen Inc.
• Hamilton Company,
• Furuno Electric Co. Ltd.

Read more about NGS-based RNA Sequencing market here: https://www.globalinsightservices.com/reports/ngs-based-rna-sequencing-market/

Global NGS-based RNA Sequencing Market Segmentation

By Product & Services
Sample Preparation
Platforms & Consumables
Services
Data Analysis

By Technology
Single-Molecule Real-Time Sequencing
Ion Semiconductor Sequencing
Sequencing By Synthesis
Nanopore Sequencing

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10519

Market Trends and Drivers
Advantages offered by NGS-based RNA sequencing such as it provides a sensitive, and accurate assay of gene expressions which is increasingly the method of choice for scientists researching on the transcriptome. Moreover, RNA sequencing based on NGS captures both known and novel features. Also, it can generate both qualitative and quantitative data, saving the research time. The market is anticipated to be driven by significant factors, including an increase in cancer incidence, government research grants, and molecular biology technical developments. Moreover, contrarily, large-scale whole-genome sequencing (WGS), one of the most preferred methods in agriculture, forensics, and biofuels, is now affordable and manageable for a typical researcher by next-generation sequencing (NGS). It enables researchers to sequence thousands of genomes in a single year or to study the whole human genome in a single sequencing session.

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10519

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

This release was published on openPR.